172@29@16@57!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php

Network18 Presents

partnered by

  • Galaxy Note20 | 20 Ultra
Moneycontrol
SENSEX NIFTY

Network18 Presents

  • partnered by
  • Galaxy Note20 | 20 Ultra
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Aug 14, 16:00
878.20 -3.10 (-0.35%)
Volume
AVERAGE VOLUME
5-Day
397,541
10-Day
316,568
30-Day
225,991
357,271
  • Prev. Close

    881.30

  • Open Price

    899.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Aug 14, 16:01
879.10 -2.20 (-0.25%)
Volume
AVERAGE VOLUME
5-Day
8,396,705
10-Day
6,821,349
30-Day
4,484,974
5,657,643
  • Prev. Close

    881.30

  • Open Price

    888.95

  • Bid Price (Qty.)

    879.10 (1012)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Profit & Loss account of Aurobindo Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 22,737.95 19,225.93 16,232.87 14,844.79 13,709.74  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 36.80 180.32 160.57  
Revenue From Operations [Net] 22,737.95 19,225.93 16,196.07 14,664.47 13,549.17  
Total Operating Revenues 23,098.50 19,563.55 16,463.03 14,909.54 13,794.65  
Other Income 86.20 155.32 101.98 115.89 203.80  
Total Revenue 23,184.70 19,718.87 16,565.01 15,025.43 13,998.45  
EXPENSES  
Cost Of Materials Consumed 7,724.98 7,444.99 5,629.38 5,184.92 4,825.56  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Employee Benefit Expenses 3,219.18 2,584.87 2,130.84 1,767.76 1,542.62  
Finance Costs 159.77 262.60 77.72 66.72 256.70  
Depreciation And Amortisation Expenses 966.71 667.95 557.97 427.63 392.37  
Other Expenses 5,319.49 4,314.10 3,810.84 3,273.24 2,901.81  
Total Expenses 19,400.38 16,542.16 13,326.97 11,969.61 11,255.60  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 3,784.32 3,176.71 3,238.04 3,055.82 2,742.85  
Exceptional Items -26.13 -88.06 0.00 0.00 0.00  
Profit/Loss Before Tax 3,758.19 3,088.65 3,238.04 3,055.82 2,742.85  
Tax Expenses-Continued Operations  
Current Tax 913.51 712.07 712.30 691.70 710.65  
Less: MAT Credit Entitlement 0.00 51.00 43.32 64.28 0.00  
Deferred Tax 0.00 65.78 149.29 132.23 10.06  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 913.51 726.85 818.27 759.65 720.71  
Profit/Loss After Tax And Before ExtraOrdinary Items 2,844.68 2,361.80 2,419.77 2,296.17 2,022.14  
Profit/Loss From Continuing Operations 2,844.68 2,361.80 2,419.77 2,296.17 2,022.14  
Profit/Loss For The Period 2,844.68 2,361.80 2,419.77 2,296.17 2,022.14  
Minority Interest 1.46 0.23 0.26 0.47 1.50  
Consolidated Profit/Loss After MI And Associates 2,830.97 2,364.73 2,423.17 2,301.66 2,025.09  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 48.00 40.00 41.00 39.00 35.00  
Diluted EPS (Rs.) 48.00 40.00 41.00 39.00 35.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 146.48 219.71 114.11 134.37  
Tax On Dividend 0.00 13.86 44.73 23.23 27.36  
Source : Dion Global Solutions Limited